The Members have appointed Dr. Abhiraj Singh Rana as an Independent Director of the Company in the 21st Annual General Meeting of the Company held on 30th September,2026.

To Date: 30.09.2026 Corporate Services The Listing Department Bombay Stock Exchange Limited Phiroz Jeejeebhoy Towers, Dalal Street, Mumbai 400 001 Scrip Code: 544571 ISIN: INE0SLP01017 Dear Sir/ Madam, Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Approval of Members for Appointment of Independent Director Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that the members of the Company, at the 21st Annual General Meeting (“AGM”) of the Company held on Wednesday, September 30, 2026, through Video Conferencing/Other Audio-Visual Means (“VC/OAVM”), have approved the appointment of Dr. Abhiraj Singh Rana (DIN: 11879073) as an Independent Director of the Company for a first term of five (5) consecutive years, commencing from August 17, 2026 to August 16, 2031. The appointment was earlier approved by the Board of Directors at its meeting held on August 17, 2026, based on the recommendation of the Nomination and Remuneration Committee, subject to the approval of the members of the Company. The requisite approval of the members has now been obtained at the 21st AGM. Dr. Abhiraj Singh Rana (DIN: 11879073) has confirmed that he is not debarred from holding the office of Director by virtue of any order of the Securities and Exchange Board of India (“SEBI”) or any other such authority and is not disqualified from being appointed as a director under the applicable provisions of law. Further, he is not related to any Director or Key Managerial Personnel of the Company. The requisite disclosure containing the details as required under Regulation 30 read with Schedule III of the SEBI Listing Regulations was made at the time of his appointment by the Board. You are requested to kindly take the above information on your record. Thanking you, FOR NSB BPO SOLUTIONS LIMITED ANJALI SHUKLA COMPANY SECRETARY Encl: Disclosure required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 read along with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023. Details required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 read along with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023. Appointment of Independent Director (Non-Executive Independent Director) Sr. Particulars Disclosures 01. Name of the Director Dr. Abhiraj Singh Rana (DIN: 11879073) 02. Reason for change viz. appointment, Dr. Abhiraj Singh Rana (DIN: 11879073) as a director re-appointment, resignation, removal, in the capacity of Non-Executive Independent death or otherwise Director of the Company. 03. Date of appointment/ re-appointment/ Appointed as an Independent Director for a first cessation (as applicable) & term of term of five (5) consecutive years, from August 17, appointment/re-appointment 2026 to August 16, 2031. The appointment was approved by the members at the 21st Annual General Meeting held on September 30, 2026. 04. Brief Profile (in case of appointment) Dr. Abhiraj Singh Rana is a board-level finance, governance and legal professional with over 10 years of experience in strategic finance, infrastructure funding, treasury management, corporate governance, regulatory compliance and board advisory. He is a Chief Financial Officer and Key Managerial Personnel, with extensive experience in infrastructure financing, financial oversight, audit, corporate governance, risk oversight, ESG and climate finance, including involvement in structuring infrastructure financing proposals. His multidisciplinary expertise in finance, governance, compliance and legal matters provides relevant experience for his proposed role as an Independent Director. 05. Disclosure of relationships between Not Applicable Directors (in case of appointment of a director). 06. Information as required under Circular Dr. Abhiraj Singh Rana is not debarred from holding No. LIST / COMP /14/ 2018-19 and the office of Director by virtue of any SEBI Order or NSE/CML/2018/02 dated 20th June, any other such authority 2018 issued by the BSE and NSE, respectively